Search

Search Constraints

You searched for: Author/Creator Antoniadou, Anastasia

Search Results

1. 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. (15th December 2022)

2. Angiotensin‐converting‐enzyme insertion/deletion polymorphism, ACE activity, and COVID‐19: A rather controversial hypothesis. A case‐control study. Issue 3 (5th November 2021)

3. Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. (13th September 2021)

4. CARDIOVASCULAR STATUS REFERENCE VALUES OF RECENTLY DIAGNOSED AND NAÏVE TO TREATMENT HUMAN IMMUNODEFICIENCY VIRUS (HIV) PATIENTS. A PILOT STUDY. (April 2021)

5. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Issue 4 (April 2018)

6. Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. (September 2020)

7. Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms. (23rd November 2019)

9. Coronavirus disease 2019 pandemic in Greece, February 26 – May 3, 2020: The first wave. Issue 41 (May 2021)

10. Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece. Issue 3 (19th June 2020)